The Hims app arranged on a smartphone in New York, US, on Wednesday, Feb. 12, 2025.
Gabby Jones | Bloomberg | Getty Images
Shares of Hims & Hers Health fell 28% on Tuesday, a day after the telehealth company released fourth-quarter results that disappointed on gross margin and sparked concerns about the future of its weight loss business.
Hims & Hers reported $481 million in revenue for the quarter, up 95% from $246.6 million during the same period last year. Net income climbed to $26.01 million, or 11 cents per share, from $1.25 million, or 1 cent per share, a year prior.
But the company’s gross margin, or the profit left after accounting for the cost of goods sold, was 77%, disappointing analysts who were expecting 78.4%, according to StreetAccount.
In the company’s quarterly call with investors on Monday, CFO Yemi Okupe said the scaling of the company’s GLP-1 offering and its strategic pricing options were to blame.
Hims & Hers in May started prescribing compounded semaglutide, the active ingredient in Novo Nordisk‘s GLP-1 weight loss medications Ozempic and Wegovy. Compounded drugs can be produced when brand-name treatments are in shortage, but the U.S. Food and Drug Administration announced Friday that the shortage of semaglutide injection products has been resolved.
As a result, Hims & Hers said Monday it will likely stop offering compounded semaglutide on its platform after its first quarter, though some consumers may still be able to access personalized doses if clinically applicable. The GLP-1 offering generated more than $225 million in revenue for the company in 2024.
“We will have to start notifying customers in the coming month or two that they will need to start looking for alternative options on the commercial dosing,” Hims & Hers CEO Andrew Dudum said on the call.
Going forward, the company said its weight loss offerings will primarily consist of its oral medications and the injectable medication liraglutide, which it plans to introduce on its platform this year.
Analysts at Morgan Stanley said in a note Tuesday the company’s report was “a lot to digest.” They maintained their equal weight rating on the stock and said they were surprised by the magnitude of the company’s 2025 guidance.
Hims & Hers said it expects between $2.3 billion to $2.4 billion in revenue this year. The company added that it expects its weight loss offerings to generate at least $725 million in revenue, excluding contributions from compounded semaglutide.
“We remain positive on the long-term opportunity, highlighting the company’s attractive platform and solid track record that differentiate it relative to digital health and DTC comps,” the Morgan Stanley analysts said.
Bank of America analysts said that while the company might have some success transitioning patients to its other weight loss offerings like its oral medications, it will face a “significant execution risk” as supply of brand-name GLP-1s increases.
Additionally, the analysts said Hims & Hers’ competitors will likely shift marketing dollars back to other products for conditions like erectile dysfunction and hair loss, which could put pressure on its advertising costs. They reiterated their underperform rating on the stock.
“Overall, we do not see upside to 2025 revenue guidance and think the beat and raise story is likely over in the near-term,” the Bank of America analysts wrote in a note Tuesday.
Citi analysts meanwhile said they think Hims & Hers revenue guidance is “aspirational,” as it would require “significant acceleration” in the use of its other weight loss products. They said they are less confident about the success of these offerings.
Even so, the analysts increased their price target on the stock to $27 from $25.
“We await a more compelling entry point and more details on growth ex-GLP-1s before we become more constructive,” they wrote in a Monday note.
Masayoshi Son, chairman and chief executive officer of SoftBank Group Corp., speaks during the company’s annual general meeting in Tokyo, Japan, on Friday, June 27, 2025.
Bloomberg | Bloomberg | Getty Images
Intel and SoftBank announced on Monday that the Japanese conglomerate will make a $2 billion investment in the embattled chipmaker.
SoftBank will pay $23 per share for Intel’s common stock, which closed on Monday at $23.66. The shares rose about 6% in extended trading to $25.
The investment makes SoftBank the fifth-biggest Intel shareholder, according to FactSet. It’s a vote of support for Intel, which hasn’t been able to take advantage of the artificial intelligence boom in advanced semiconductors and has spent heavily to stand up a manufacturing business that’s yet to secure a significant customer.
“Masa and I have worked closely together for decades, and I appreciate the confidence he has placed in Intel with this investment,” Intel CEO Lip-Bu Tan said in a statement, referring to SoftBank founder Masayoshi Son.
Intel shares lost 60% of their value last year, their worst performance in the company’s more than half-century on the public market. The stock is up 18% in 2025 as of Monday’s close.
Tan took over as Intel CEO in March after his predecessor, Pat Gelsinger, was ousted in December.
Intel has been a major topic of discussion in Washington of late, due to the company’s role as the only American company capable of manufacturing the most advanced chips.
However, Intel’s foundry business, which is designed to manufacture chips for other companies, has yet to secure a major customer, a critical step towards stabilization and expansion. Last month, Intel said it would wait to secure orders before committing to certain future investment in its foundry.
Tan met with President Donald Trump last week after the president had called for the CEO’s resignation. The U.S. government is considering taking an equity stake in Intel, according to reports.
SoftBank, meanwhile, has become an increasingly large player in the global chip and AI markets.
In 2016, SoftBank acquired chip designer Arm in a deal worth about $32 billion at the time. Today the company is worth almost $150 billion. Arm-based chips are part of Nvidia’s systems that go into data centers.
SoftBank was also part of President Trump’s Stargate announcement in January, along with OpenAI and Oracle.
The three companies committed to invest an initial $100 billion and up to $500 billion over the next four years in the AI infrastructure project. Two months later, SoftBank led a $40 billion investment into OpenAI, the largest private tech deal on record.
“This strategic investment reflects our belief that advanced semiconductor manufacturing and supply will further expand in the United States, with Intel playing a critical role,” Son said in a statement.
Nikesh Arora, CEO of Palo Alto Networks, looks on during the closing bell at the Nasdaq Market in New York City on March 25, 2025.
Jeenah Moon | Reuters
Palo Alto Networks reported better-than-expected quarterly results and issued upbeat guidance for the current period. The cybersecurity software vendor said Nir Zuk, who founded the company in 2005, is retiring from his role as chief technology officer.
The stock rose about 6% in extended trading.
Here’s how the company did compared to LSEG estimates:
Earnings: 95 cents adjusted vs. 88 cents expected
Revenue: $2.54 billion vs. $2.5 billion expected.
Revenue in the fiscal fourth quarter rose 16% from about $2.2 billion last year, the company said in a statement. Net income fell to about $254 million, or 36 cents per share, from about $358 million, or 51 cents per share, in the year-ago period.
The company also issued upbeat guidance for the fiscal first quarter. Earnings per share will be between 88 cents and 90 cents, Palo Alto said, topping an 85-cents estimate from StreetAccount.
For the full year, Palo Alto said revenue will range from $10.48 billion to $10.53 billion on adjusted earnings of $3.75 to $3.85 per share. Both estimates exceeded Wall Street’s projections.
Palo Alto said that for the fiscal first quarter, remaining purchase obligations, which tracks backlog, will range between $15.4 billion and $15.5 billion, surpassing a $15.07 billion estimate.
Last month, the company announced plans to buy Israeli identity security provider CyberArk for $25 billion. It’s the largest deal Palo Alto has made since its founding, and most ambitious in an acquiring spree that ramped up after CEO Nikesh Arora took the helm of the company in 2018.
Shares sold off sharply after the news broke and have yet to recover previous highs. The stock is down about 3% this year as of Monday’s close.
“We look for great products, a team that can execute in the product, and we let them run it,” Arora told CNBC following the announcement. “This is going to be a different challenge, but we’ve done well 24 times, so I’m pretty confident that our team can handle this.”
Lee Klarich, the company’s product chief, will replace Zuk as CTO and fill his position on the board.
Satellite internet service Starlink, which is owned and operated by Elon Musk‘s SpaceX, appeared to suffer a brief network outage on Monday, with thousands of reports of service interruptions on Downdetector, a site that logs tech issues.
The outage marked the second in two weeks for Starlink. SpaceX did not immediately respond to a request for comment.
The network’s July 24 outage lasted for several hours, with SpaceX Vice President of Starlink Engineering Michael Nicolls blaming the matter on “failure of key internal software services that operate the core network” behind Starlink.
That outage followed the launch of T-Mobile‘s Starlink-powered satellite service, a direct-to-cell-phone service created to keep smartphone users connected “in places no carrier towers can reach,” according to T-Mobile’s website.
SpaceX provides Starlink internet service to more than six million users across 140 countries, according to the company’s website, though churn and subscriber rates are not publicly reported by the company.
Read more CNBC tech news
The SpaceX Starlink constellation is far larger than any competitor. It currently features over 7,000 operational broadband satellites, according to research by astronomer Jonathan McDowell.
On Monday, Musk’s SpaceX successfully launched another group of satellites to add to its Starlink constellation from the Vandenberg Space Force Base in Southern California.
SpaceX is currently aiming to increase the number of launches and landings from Vandenberg from 50 to about 100 annually.
On Thursday last week, the California Coastal Commission voted unanimously to oppose the U.S. Space Force application to conduct that higher volume of SpaceX launches there.
The Commission has said that SpaceX and Space Force officials have failed to properly evaluate and report on potential impacts of increased launches on neighboring towns, and local wildlife, among other issues.
President Donald Trump recently signed an executive order seeking to ease environmental regulations seen by Musk, and others, as hampering commercial space operations.